Cases of the Year Submissions

Call for Cases
SPD's 30th Annual Pre-AAD Meeting
February 15, 2018 | San Diego, California

Deadline: December 15, 2017

Click here to submit your case.


Cases of the Year includes cases with a known diagnosis, diseases that were difficult to diagnose, or cases presenting management challenges. These cases should have attendant teaching value. Case presentations are four minutes, with an additional two-minute question & answer period. Ten cases will be selected for the Pre-AAD Meeting.

Important Submission Information

  • All cases must be submitted via the online form.
  • Case summaries can be up to 2,700 characters, including spaces.
  • Case submissions must be accompanied by photos. Please submit .jpg files less than 2MB. Cases submitted without photos will not be considered.
  • Previously published/presented work will be considered, but please note on the submission form when and where it was published or presented.
  • Submitters will be notified on or before January 18, 2018.
  • Case presenters must register for the meeting.
  • Multiple cases per institution may be accepted; but no more than one case per senior author will be accepted.
  • Review process will be blinded.

Click here to submit your case.

Attention Fellows, Residents, and Medical Students - Travel Award Available

One travel award is available on a competitive basis to fellows, residents, and medical students who are SPD members and present a Case of the Year Pre-AAD Meeting. This is an effort to encourage participation among trainees interested in pediatric dermatology and helps provide recognition for exceptional work as well as financial assistance to attend the meeting. There will be one $1,000 award available for the SPD Pre-AAD Meeting. Members who qualify may apply through the SPD website at the time of case submission. The SPD Awards and Goals Committee will evaluate the quality of the case, focusing on whether it presents “new” information, is relevant to care of children with skin diseases, quality of data, and approved consent process.